Related references
Note: Only part of the references are listed.Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
Ahmed M. Kabel et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2015)
World Gastroenterology Organisation Global Guidelines Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Douglas R. LaBrecque et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Peroxisome Proliferator Activator Receptor (PPAR)-γ Ligand, but Not PPAR-α, Ameliorates Cyclophosphamide- Induced Oxidative Stress and Inflammation in Rat Liver
Azza A. K. El-Sheikh et al.
PPAR RESEARCH (2014)
The chemical chaperon 4-phenylbutyric acid ameliorates hepatic steatosis through inhibition of de novo lipogenesis in high-fructose-fed rats
Lu-Ping Ren et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning
Juliana G. Franco et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Resveratrol Metabolites Modify Adipokine Expression and Secretion in 3T3-L1 Pre-Adipocytes and Mature Adipocytes
Itziar Eseberri et al.
PLOS ONE (2013)
Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway
Wei-Lu Chen et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes
Sho-ichi Yamagishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
S. Gomez-Zorita et al.
BRITISH JOURNAL OF NUTRITION (2012)
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease
Kyoko Nomura et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Resveratrol induces Sirtl-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression
Sifan Chen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice
Soyoung Kim et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Effect of galangin supplementation on oxidative damage and inflammatory changes in fructose-fed rat liver
Allur Subramaniyan Sivakumar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Adipose Tissue Vascularization: Its Role in Chronic Inflammation
Jianping Ye
CURRENT DIABETES REPORTS (2011)
Fructose at the Center of Necroinflammation and Fibrosis in Nonalcoholic Steatohepatitis
Anna Alisi et al.
HEPATOLOGY (2011)
A Resveratrol and Polyphenol Preparation Suppresses Oxidative and Inflammatory Stress Response to a High-Fat, High-Carbohydrate Meal
Husam Ghanim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and upregulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage?
Shuai-nan Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury
Che-Chang Chan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndrome
Hiroaki Ueno et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Distinct Effects of Calorie Restriction and Resveratrol on Diet-Induced Obesity and Fatty Liver Formation
Eveliina Tauriainen et al.
JOURNAL OF NUTRITION AND METABOLISM (2011)
Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome
Mark J. Dekker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Canto et al.
CELL METABOLISM (2010)
SIRT1 mRNA Expression May Be Associated With Energy Expenditure and Insulin Sensitivity
Jarno Rutanen et al.
DIABETES (2010)
Fenofibrate Treatment Enhances Antioxidant Status and Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats
Murat Olukman et al.
EXPERIMENTAL DIABETES RESEARCH (2010)
The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats
Weihong Li et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Luc Tappy et al.
PHYSIOLOGICAL REVIEWS (2010)
Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats
H. Yadav et al.
DIGESTIVE AND LIVER DISEASE (2009)
Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice
Maaike H. Oosterveer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle
Zhengshan Zhao et al.
LIFE SCIENCES (2009)
Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats
Tetsuya Ohta et al.
TOXICOLOGIC PATHOLOGY (2009)
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
Jing Shang et al.
ACTA PHARMACOLOGICA SINICA (2008)
The Metabolic Syndrome
Marc-Andre Cornier et al.
ENDOCRINE REVIEWS (2008)
The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice
Wei-Na Cong et al.
LIFE SCIENCES (2008)
Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes
Srujana Rayalam et al.
PHYTOTHERAPY RESEARCH (2008)
Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release
Yu-Jung Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Resveratrol prevents fibrosis, NF-kappa B activation and TGF-beta increases induced by chronic CCl4 treatment in rats
Enrique Chavez et al.
JOURNAL OF APPLIED TOXICOLOGY (2008)
Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance
Razieh Jalal et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
The evolving role of leptin and adiponectin in chronic liver diseases
Emmanuel Tsochatzis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
The AST/ALT ratio as an indicator of cirrhosis in patients with PBC
Helena Nyblom et al.
LIVER INTERNATIONAL (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome
K Ueki et al.
HEPATOLOGY RESEARCH (2005)
Molecular and anatomical determinants of central leptin resistance
H Münzberg et al.
NATURE NEUROSCIENCE (2005)
Peroxisomal-proliferator-activated receptor α activates transcription of the rat hepatic malonyl-CoA decarboxylase gene:: a key regulation of malonyl-CoA level
GY Lee et al.
BIOCHEMICAL JOURNAL (2004)
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
VT Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking
H Nyblom et al.
ALCOHOL AND ALCOHOLISM (2004)
Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3
JK Howard et al.
NATURE MEDICINE (2004)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Amelioration of high fructose-induced metabolic derangements by activation of PPARα
Y Nagai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Y Minokoshi et al.
NATURE (2002)
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice
B Emanuelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals
K Ikejima et al.
HEPATOLOGY (2001)
Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis.
H Tilg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
